Novo CEO pressed by Senate to cut rates of obesity, diabetes prescription drugs CEO Lars Fruergaard Jørgensen told lawmakers the organization would take into account new talks with insurers in regards to the record rates of Wegovy and copyright when they pledge to help keep the medicines on their own https://buschlightpeachcalories19630.ampblogs.com/the-healthcare-news-diaries-67461470